Amedeo Smart

Free Medical Literature Service



Chronic Heart Failure

  Free Subscription

Articles published in
    September 2021
  1. LIMPITIKUL WB, Dewland TA, Vittinghoff E, Soliman E, et al
    Premature ventricular complexes and development of heart failure in a community-based population.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319473. doi: 10.1136/heartjnl-2021-319473.
    >> Share

  2. NASER JA, Pislaru S, Stan MN, Lin G, et al
    Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease.
    Heart. 2021 Sep 6. pii: heartjnl-2021-319752. doi: 10.1136/heartjnl-2021-319752.
    >> Share

    August 2021
  3. HASSAN R, Ahmed SB
    Sex differences in heart failure and precision medicine: right patient, right time...wrong dose?
    Heart. 2021 Aug 18. pii: heartjnl-2021-319831. doi: 10.1136/heartjnl-2021-319831
    >> Share

  4. SINGH A, Agarwal A, Wafford QE, Shah SJ, et al
    Efficacy and safety of diuretics in heart failure with preserved ejection fraction: a scoping review.
    Heart. 2021 Aug 2. pii: heartjnl-2021-319643. doi: 10.1136/heartjnl-2021-319643.
    >> Share

  5. RAMAKUMAR V, Arvind B, Deepti S
    A young man with acute heart failure and a holodiastolic murmur.
    Heart. 2021;107:1288-1356.
    >> Share

    July 2021
  6. BOTS SH, Onland-Moret NC, Tulevski II, van der Harst P, et al
    Heart failure medication dosage and survival in women and men seen at outpatient clinics.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319229. doi: 10.1136/heartjnl-2021-319229
    >> Share

    June 2021
  7. TAYLOR CJ, Lay-Flurrie SL, Ordonez-Mena JM, Goyder CR, et al
    Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004-2018.
    Heart. 2021 Jun 28. pii: heartjnl-2021-319196. doi: 10.1136/heartjnl-2021-319196
    >> Share

  8. DOCHERTY KF, Petrie MC
    Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure.
    Heart. 2021 Jun 14. pii: heartjnl-2020-318658. doi: 10.1136/heartjnl-2020-318658
    >> Share

  9. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    >> Share

  10. DESAI RJ, Patorno E, Vaduganathan M, Mahesri M, et al
    Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319405. doi: 10.1136/heartjnl-2021-319405.
    >> Share

  11. GRIFFIN J, Cheng R
    Real-world utilisation of angiotensin-neprilysin inhibitors in older adults with heart failure.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319545. doi: 10.1136/heartjnl-2021-319545.
    >> Share

    May 2021
  12. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    >> Share

  13. DESJARDIN J, Leyde S, Davis J
    Weathering the perfect storm: management of heart failure in patients with substance use disorders.
    Heart. 2021 May 24. pii: heartjnl-2021-319103. doi: 10.1136/heartjnl-2021-319103
    >> Share

  14. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    >> Share

  15. CHUA W, Fabritz L
    Heart failure in patients with atrial fibrillation: why it matters now more than ever.
    Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145
    >> Share

  16. LADOUCEUR M, Segura de la Cal T, Gaye B, Valentin E, et al
    Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle.
    Heart. 2021 May 6. pii: heartjnl-2020-318787. doi: 10.1136/heartjnl-2020-318787.
    >> Share

    March 2021
  17. ROMAINE SPR, Denniff M, Codd V, Nath M, et al
    Telomere length is independently associated with all-cause mortality in chronic heart failure.
    Heart. 2021 Mar 31. pii: heartjnl-2020-318654. doi: 10.1136/heartjnl-2020-318654
    >> Share

    Neurohormones and death in systolic heart failure: keep your friends close, but your enemies closer.
    Heart. 2021 Mar 18. pii: heartjnl-2021-319153. doi: 10.1136/heartjnl-2021-319153
    >> Share

  19. AIMO A, Prontera C, Passino C, Emdin M, et al
    Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failure.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318791. doi: 10.1136/heartjnl-2020-318791
    >> Share

  20. WEBER C, Hung J, Hickling S, Nedkoff L, et al
    Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation.
    Heart. 2021 Mar 11. pii: heartjnl-2020-318648. doi: 10.1136/heartjnl-2020-318648
    >> Share

  21. BUNTING KV, Gill SK, Sitch A, Mehta S, et al
    Improving the diagnosis of heart failure in patients with atrial fibrillation.
    Heart. 2021 Mar 10. pii: heartjnl-2020-318557. doi: 10.1136/heartjnl-2020-318557
    >> Share

    February 2021
  22. JOSHI SS, Singh T, Newby DE, Singh J, et al
    Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
    Heart. 2021 Feb 26. pii: heartjnl-2020-318060. doi: 10.1136/heartjnl-2020-318060
    >> Share

    Heart failure in adults with congenital heart disease: a call for action.
    Heart. 2021 Feb 23. pii: heartjnl-2020-318757. doi: 10.1136/heartjnl-2020-318757
    >> Share

  24. NISHIKAWA Y, Fukahori H, Mizuno A, Kwong JS, et al
    Cochrane corner: advance care planning for adults with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-318458. doi: 10.1136/heartjnl-2020-318458
    >> Share

  25. YAMAMOTO S, Yamaga T, Kawachi S, Shibuya M, et al
    Cochrane corner: Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-317888. doi: 10.1136/heartjnl-2020-317888
    >> Share

    January 2021
  26. WU J, Hall AS, Gale CP
    Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Heart. 2021 Jan 15. pii: heartjnl-2020-316823. doi: 10.1136/heartjnl-2020-316823
    >> Share

  27. MOHEBALI D, Kittleson MM
    Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318062. doi: 10.1136/heartjnl-2020-318062
    >> Share

  28. YANDRAPALLI S, Malik A, Pemmasani G, Aronow W, et al
    Sex differences in heart failure hospitalisation risk following acute myocardial infarction.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318306. doi: 10.1136/heartjnl-2020-318306
    >> Share

  29. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Response to 'Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction'.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318849. doi: 10.1136/heartjnl-2020-318849.
    >> Share

  30. ALBUQUERQUE LL, Meira E Cruz M, Salles C
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318762. doi: 10.1136/heartjnl-2020-318762.
    >> Share

    December 2020
  31. BLACHER M, Zimerman A, Engster PHB, Grespan E, et al
    Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II.
    Heart. 2020 Dec 23. pii: heartjnl-2020-317984. doi: 10.1136/heartjnl-2020-317984
    >> Share

  32. BURSTEIN DS, Rossano JW, Griffis H, Zhang X, et al
    Greater admissions, mortality and cost of heart failure in adults with congenital heart disease.
    Heart. 2020 Dec 23. pii: heartjnl-2020-318246. doi: 10.1136/heartjnl-2020-318246
    >> Share

    November 2020
  33. HAMATANI Y, Iguchi M, Ueno K, Aono Y, et al
    Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
    Heart. 2020 Nov 20. pii: heartjnl-2020-317735. doi: 10.1136/heartjnl-2020-317735
    >> Share

  34. REARDON L, Lin J
    Advanced heart failure and transplant in congenital heart disease.
    Heart. 2020 Nov 13. pii: heartjnl-2019-316366. doi: 10.1136/heartjnl-2019-316366
    >> Share

  35. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2020 Nov 6. pii: heartjnl-2020-317326. doi: 10.1136/heartjnl-2020-317326.
    >> Share

  36. DROZD M, Relton SD, Walker AMN, Slater TA, et al
    Association of heart failure and its comorbidities with loss of life expectancy.
    Heart. 2020 Nov 5. pii: heartjnl-2020-317833. doi: 10.1136/heartjnl-2020-317833.
    >> Share

  37. ZIMERMAN A, Rohde LE
    Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure.
    Heart. 2020 Nov 2. pii: heartjnl-2020-317977. doi: 10.1136/heartjnl-2020-317977.
    >> Share

    October 2020
  38. HUNG CL, Chao TF, Su CH, Liao JN, et al
    Income level and outcomes in patients with heart failure with universal health coverage.
    Heart. 2020 Oct 20. pii: heartjnl-2020-316793. doi: 10.1136/heartjnl-2020-316793
    >> Share

  39. MULDER BA, Rienstra M, Blaauw Y
    Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
    Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
    >> Share

  40. BHATIA HS, Nishimura M, Dickson S, Adler E, et al
    Clinical and echocardiographic outcomes in heart failure associated with methamphetamine use and cessation.
    Heart. 2020 Oct 5. pii: heartjnl-2020-317635. doi: 10.1136/heartjnl-2020-317635.
    >> Share

    Atrial fibrillation in heart failure with preserved ejection fraction: a risk marker, risk factor or confounder?
    Heart. 2020 Oct 5. pii: heartjnl-2020-317978. doi: 10.1136/heartjnl-2020-317978.
    >> Share

  42. MOCERI P, Lopez S, Ferrari E
    Atypical right heart failure in a septuagenarian.
    Heart. 2020;106:1524-1536.
    >> Share

    September 2020
  43. BERGLUND F, Pina P, Herrera CJ
    Right ventricle in heart failure with preserved ejection fraction.
    Heart. 2020 Sep 7. pii: heartjnl-2020-317342. doi: 10.1136/heartjnl-2020-317342.
    >> Share

    August 2020
  44. PERRY AS, Mann DL, Brown DL
    Improvement of ejection fraction and mortality in ischaemic heart failure.
    Heart. 2020 Aug 25. pii: heartjnl-2020-316975. doi: 10.1136/heartjnl-2020-316975
    >> Share

  45. ZHANG X, Wang S, Liu J, Wang Y, et al
    D-dimer and the incidence of heart failure and mortality after acute myocardial infarction.
    Heart. 2020 Aug 12. pii: heartjnl-2020-316880. doi: 10.1136/heartjnl-2020-316880
    >> Share

  46. SCHRAGE B, Lund LH, Benson L, Stolfo D, et al
    Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure.
    Heart. 2020 Aug 7. pii: heartjnl-2020-317216. doi: 10.1136/heartjnl-2020-317216.
    >> Share

    July 2020
    NICE heart failure guidelines: the diagnostic algorithm in practice, what is the next step?
    Heart. 2020 Jul 20. pii: heartjnl-2020-317450. doi: 10.1136/heartjnl-2020-317450
    >> Share

  48. ZHENG A, Cowan E, Mach L, Adam RD, et al
    Characteristics and outcomes of patients with suspected heart failure referred in line with National Institute for Health and Care Excellence guidance.
    Heart. 2020 Jul 20. pii: heartjnl-2019-316511. doi: 10.1136/heartjnl-2019-316511
    >> Share

  49. DARDAS T, Dorsch MP
    Remote management of heart failure: Herculean or Sisyphean task?
    Heart. 2020 Jul 9. pii: heartjnl-2020-317270. doi: 10.1136/heartjnl-2020-317270.
    >> Share

    June 2020
  50. RAHIMI K, Nazarzadeh M, Pinho-Gomes AC, Woodward M, et al
    Home monitoring with technology-supported management in chronic heart failure: a randomised trial.
    Heart. 2020 Jun 24. pii: heartjnl-2020-316773. doi: 10.1136/heartjnl-2020-316773
    >> Share

  51. MARINI C, Fragasso G, Italia L, Sisakian H, et al
    Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure.
    Heart. 2020 Jun 22. pii: heartjnl-2019-316429. doi: 10.1136/heartjnl-2019-316429
    >> Share

  52. ROSANO G, Savarese G
    Inter-twinned relationship between heart failure and atrial fibrillation.
    Heart. 2020 Jun 1. pii: heartjnl-2020-316886. doi: 10.1136/heartjnl-2020-316886.
    >> Share

    April 2020
  53. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    >> Share

  54. HONG SH, Lee JS, Kim JA, Lee YB, et al
    Gamma-glutamyl transferase variability and the risk of hospitalisation for heart failure.
    Heart. 2020 Apr 17. pii: heartjnl-2019-316271. doi: 10.1136/heartjnl-2019-316271
    >> Share

  55. OTTO CM
    Heartbeat: risk of stroke in patients with heart failure.
    Heart. 2020;106:549-551.
    >> Share

    March 2020
  56. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    >> Share

  57. OTTO CM
    Heartbeat: can machine learning improve outcomes in patients with heart failure with preserved ejection fraction?
    Heart. 2020;106:315-317.
    >> Share

  58. CHEN S, Banerjee A
    Machine learning: a long way from implementation in cardiovascular disease.
    Heart. 2020;106:318-320.
    >> Share

    February 2020
  59. ERGATOUDES C, Hansson PO, Svardsudd K, Rosengren A, et al
    Comparison of incidence rates and risk factors of heart failure between two male cohorts born 30 years apart.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316059. doi: 10.1136/heartjnl-2019-316059
    >> Share

  60. CHEHAB O, Roberts-Thomson R, Ng Yin Ling C, Marber M, et al
    Secondary mitral regurgitation: pathophysiology, proportionality and prognosis.
    Heart. 2020 Feb 13. pii: heartjnl-2019-316238. doi: 10.1136/heartjnl-2019-316238
    >> Share

    Ethnicity, heart failure and the prevention continuum: time to act.
    Heart. 2020 Feb 6. pii: heartjnl-2019-316293. doi: 10.1136/heartjnl-2019-316293.
    >> Share

  62. BEGUE C, Morner S, Brito D, Hengstenberg C, et al
    Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Heart. 2020;106:196-202.
    >> Share

  63. TOBLER D, Greutmann M
    Simple cardiac shunts in adults: atrial septal defects, ventricular septal defects, patent ductus arteriosus.
    Heart. 2020;106:307-314.
    >> Share

  64. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
    Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
    Heart. 2020;106:248-250.
    >> Share

    January 2020
  65. NELSON AJ, Patel MR
    Ischaemic stroke in heart failure: back to basics?
    Heart. 2020 Jan 27. pii: heartjnl-2019-315957. doi: 10.1136/heartjnl-2019-315957
    >> Share

  66. HEDMAN AK, Hage C, Sharma A, Brosnan MJ, et al
    Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning.
    Heart. 2020 Jan 7. pii: heartjnl-2019-315481. doi: 10.1136/heartjnl-2019-315481.
    >> Share

  67. GALLEGO P, Oliver JM
    Medical therapy for heart failure in adult congenital heart disease: does it work?
    Heart. 2020;106:154-162.
    >> Share

    December 2019
  68. UEBERHAM L, Konig S, Hohenstein S, Mueller-Roething R, et al
    Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315566. doi: 10.1136/heartjnl-2019-315566
    >> Share

  69. OSTERGAARD L, Dahl A, Bruun NE, Oestergaard LB, et al
    Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure.
    Heart. 2019 Dec 10. pii: heartjnl-2019-315715. doi: 10.1136/heartjnl-2019-315715
    >> Share

  70. WOOD K, Gladwin M, Straub A
    Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure.
    Heart. 2019 Dec 10. pii: heartjnl-2019-314810. doi: 10.1136/heartjnl-2019-314810
    >> Share

    October 2019
  71. CHOU YL, Liou JT, Cheng CC, Tsai MC, et al
    The association of ischaemic stroke in patients with heart failure without atrial flutter/fibrillation.
    Heart. 2019 Oct 3. pii: heartjnl-2019-315646. doi: 10.1136/heartjnl-2019-315646.
    >> Share

  72. OTTO CM
    Heartbeat: oxygen transport close to and far from the ventricle in heart failure.
    Heart. 2019;105:1525-1527.
    >> Share

    September 2019
  73. MAHAJAN R, Stokes M, Elliott A, Munawar DA, et al
    Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis.
    Heart. 2019 Sep 17. pii: heartjnl-2019-314770. doi: 10.1136/heartjnl-2019-314770
    >> Share

  74. AHN MS, Yoo BS, Yoon J, Lee SH, et al
    Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315240. doi: 10.1136/heartjnl-2019-315240.
    >> Share

  75. BERNARD S, Hung J
    Managing tricuspid valve regurgitation: a long and winding road.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315696. doi: 10.1136/heartjnl-2019-315696.
    >> Share

    August 2019
  76. RODRIGUES BS, David C, Costa J, Ferreira JJ, et al
    Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies.
    Heart. 2019 Aug 23. pii: heartjnl-2019-315193. doi: 10.1136/heartjnl-2019-315193
    >> Share

  77. REDDY YNV, Nishimura R
    Intervening for tricuspid regurgitation: uncertainties in a heterogeneous syndrome.
    Heart. 2019 Aug 23. pii: heartjnl-2019-315624. doi: 10.1136/heartjnl-2019-315624
    >> Share

  78. ZHANG H, El-Am EA, Thaden JJ, Pislaru SV, et al
    Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.
    Heart. 2019 Aug 22. pii: heartjnl-2019-314996. doi: 10.1136/heartjnl-2019-314996
    >> Share

  79. KADRI AN, Menon V, Sammour YM, Gajulapalli RD, et al
    Outcomes of patients with severe tricuspid regurgitation and congestive heart failure.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315004. doi: 10.1136/heartjnl-2019-315004
    >> Share

  80. FROEHLICH L, Meyre P, Aeschbacher S, Blum S, et al
    Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315174. doi: 10.1136/heartjnl-2019-315174
    >> Share

    July 2019
  81. SILLARS A, Ho FK, Pell GP, Gill JMR, et al
    Sex differences in the association of risk factors for heart failure incidence and mortality.
    Heart. 2019 Jul 31. pii: heartjnl-2019-314878. doi: 10.1136/heartjnl-2019-314878
    >> Share

  82. WANG F, Harel-Sterling L, Cohen S, Liu A, et al
    Heart failure risk predictions in adult patients with congenital heart disease: a systematic review.
    Heart. 2019 Jul 26. pii: heartjnl-2019-314977. doi: 10.1136/heartjnl-2019-314977
    >> Share

  83. LUMBERS RT, Martin N, Manoharan K, Thomas J, et al
    Do beta-blockers and inhibitors of the renin-angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%?
    Heart. 2019 Jul 25. pii: heartjnl-2018-313855. doi: 10.1136/heartjnl-2018-313855
    >> Share

  84. NEPPER-CHRISTENSEN L, Hofsten DE, Helqvist S, Lassen JF, et al
    Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.
    Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952
    >> Share

  85. CROSSLAND DS, Jansen K, Parry G, Harper A, et al
    Outcome following heart transplant assessment in adults with congenital heart disease.
    Heart. 2019 Jul 5. pii: heartjnl-2019-314711. doi: 10.1136/heartjnl-2019-314711.
    >> Share

    June 2019
  86. HEARON CM JR, Sarma S, Dias KA, Hieda M, et al
    Impaired oxygen uptake kinetics in heart failure with preserved ejection fraction.
    Heart. 2019 Jun 17. pii: heartjnl-2019-314797. doi: 10.1136/heartjnl-2019-314797
    >> Share

  87. CLARK AL, Kalra PR, Petrie MC, Mark PB, et al
    Change in renal function associated with drug treatment in heart failure: national guidance.
    Heart. 2019;105:904-910.
    >> Share

  88. TAN ESJ, Tay WT, Teng TK, Richards AM, et al
    The diabetes-atrial fibrillation paradox.
    Heart. 2019;105:893.
    >> Share

  89. GERDTS E, Saeed S, Midtbo H, Rossebo A, et al
    Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis.
    Heart. 2019 Jun 1. pii: heartjnl-2018-314462. doi: 10.1136/heartjnl-2018-314462.
    >> Share

    May 2019
  90. ONG G, Pibarot P
    Combined aortic stenosis and regurgitation: double the trouble.
    Heart. 2019 May 29. pii: heartjnl-2017-312303. doi: 10.1136/heartjnl-2017-312303
    >> Share

  91. SCHICHTEL M, Wee B, Perera R, Onakpoya I, et al
    Clinician-targeted interventions to improve advance care planning in heart failure: a systematic review and meta-analysis.
    Heart. 2019 May 22. pii: heartjnl-2019-314758. doi: 10.1136/heartjnl-2019-314758
    >> Share

  92. OTTO CM
    Heartbeat: Primary care delays in heart failure diagnosis.
    Heart. 2019;105:661-662.
    >> Share

    April 2019
  93. SALAH K, Stienen S, Pinto YM, Eurlings LW, et al
    Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314173. doi: 10.1136/heartjnl-2018-314173.
    >> Share

  94. BEGGS SAS, Rorth R, Gardner RS, McMurray JJV, et al
    Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314381. doi: 10.1136/heartjnl-2018-314381.
    >> Share

  95. GALLAGHER C, Hendriks JM, Giles L, Karnon J, et al
    Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013.
    Heart. 2019 Apr 1. pii: heartjnl-2018-314471. doi: 10.1136/heartjnl-2018-314471.
    >> Share

    March 2019
  96. CHRISTIANSEN MN, Kober L, Torp-Pedersen C, Smith JG, et al
    Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy.
    Heart. 2019 Mar 25. pii: heartjnl-2018-314552. doi: 10.1136/heartjnl-2018-314552
    >> Share

  97. ANDERSON LJ, Squire IB, Cowie MR
    Global lessons from deaths from heart failure in UK hospitals.
    Heart. 2019 Mar 2. pii: heartjnl-2018-314641. doi: 10.1136/heartjnl-2018-314641.
    >> Share

    February 2019
  98. FROHLICH H, Rosenfeld N, Tager T, Goode K, et al
    Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
    Heart. 2019 Feb 21. pii: heartjnl-2018-314256. doi: 10.1136/heartjnl-2018-314256
    >> Share

  99. BURDEN AF, Timpson N
    Ethnicity, heart failure, atrial fibrillation and diabetes: collider bias.
    Heart. 2019 Feb 6. pii: heartjnl-2018-314467. doi: 10.1136/heartjnl-2018-314467.
    >> Share

  100. Correction: Heart rate: surrogate or target in the management of heart failure?
    Heart. 2019;105:e1.
    >> Share

    January 2019
    Creating order out of chaos: quality of care in heart failure.
    Heart. 2019 Jan 31. pii: heartjnl-2018-314526. doi: 10.1136/heartjnl-2018-314526
    >> Share

  102. AGARWAL A, Bahiru E, Yoo SGK, Berendsen MA, et al
    Hospital-based quality improvement interventions for patients with heart failure: a systematic review.
    Heart. 2019 Jan 30. pii: heartjnl-2018-314129. doi: 10.1136/heartjnl-2018-314129
    >> Share

  103. PINHO-GOMES AC, Rahimi K
    Management of blood pressure in heart failure.
    Heart. 2019 Jan 23. pii: heartjnl-2018-314438. doi: 10.1136/heartjnl-2018-314438
    >> Share

  104. TAN ESJ, Tay WT, Teng TK, Sim D, et al
    Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific.
    Heart. 2019 Jan 19. pii: heartjnl-2018-314077. doi: 10.1136/heartjnl-2018-314077
    >> Share

  105. TAYLOR CJ
    Diagnosing heart failure: challenges in primary care.
    Heart. 2019 Jan 15. pii: heartjnl-2018-314396. doi: 10.1136/heartjnl-2018-314396
    >> Share

  106. DIMOPOULOS K, Muthiah K, Alonso-Gonzalez R, Banner NR, et al
    Heart or heart-lung transplantation for patients with congenital heart disease in England.
    Heart. 2019 Jan 12. pii: heartjnl-2018-313984. doi: 10.1136/heartjnl-2018-313984
    >> Share

  107. OTTO CM
    Heartbeat: heart failure induced by cancer therapy.
    Heart. 2019;105:1-3.
    >> Share

    December 2018
  108. NAKATSUMA K, Taniguchi T, Morimoto T, Shiomi H, et al
    B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis.
    Heart. 2018 Dec 7. pii: heartjnl-2018-313746. doi: 10.1136/heartjnl-2018-313746.
    >> Share

  109. HAYHOE B, Kim D, Aylin PP, Majeed FA, et al
    Adherence to guidelines in management of symptoms suggestive of heart failure in primary care.
    Heart. 2018 Dec 4. pii: heartjnl-2018-313971. doi: 10.1136/heartjnl-2018-313971.
    >> Share

  110. DEFARIA YEH D, Stefanescu Schmidt AC, Eisman AS, Serfas JD, et al
    Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease.
    Heart. 2018;104:2044-2050.
    >> Share

    October 2018
  111. AL RIFAI M, Blaha MJ, Rahman F, Ehrman JK, et al
    Inverse association of pulse pressure augmentation during exercise with heart failure and death.
    Heart. 2018 Oct 25. pii: heartjnl-2018-313736. doi: 10.1136/heartjnl-2018-313736
    >> Share

  112. MILANI GP, Bianchetti MG, Lava SA
    Measurement of sodium in heart failure.
    Heart. 2018;104:1724.
    >> Share

  113. BUBER J, Valente AM
    Predicting survival in adults with congenital heart disease: what are the odds?
    Heart. 2018;104:1643-1644.
    >> Share

    September 2018
  114. NTILOUDI D, Apostolopoulou S, Vasiliadis K, Frogoudaki A, et al
    Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313613. doi: 10.1136/heartjnl-2018-313613
    >> Share

  115. LEE SE, Lee HY, Cho HJ, Choe WS, et al
    Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313242. doi: 10.1136/heartjnl-2018-313242
    >> Share

  116. BHAGRA SK, Pettit S, Parameshwar J
    Cardiac transplantation: indications, eligibility and current outcomes.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313103. doi: 10.1136/heartjnl-2018-313103
    >> Share

  117. DIBBEN GO, Dalal HM, Taylor RS, Doherty P, et al
    Cardiac rehabilitation and physical activity: systematic review and meta-analysis.
    Heart. 2018;104:1394-1402.
    >> Share

  118. KRUPICKOVA S, Morgan GJ, Cheang MH, Rigby ML, et al
    Symptomatic partial and transitional atrioventricular septal defect repaired in infancy.
    Heart. 2018;104:1411-1416.
    >> Share

    August 2018
  119. SZE S, Pellicori P, Zhang J, Clark AL, et al
    Malnutrition, congestion and mortality in ambulatory patients with heart failure.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313312. doi: 10.1136/heartjnl-2018-313312
    >> Share

  120. WOLFSON AM, Fong M, Grazette L, Rahman JE, et al
    Chronic heart failure management and remote haemodynamic monitoring.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313397. doi: 10.1136/heartjnl-2018-313397
    >> Share

  121. HUANG W, Su L, Wu S, Xu L, et al
    Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313415. doi: 10.1136/heartjnl-2018-313415.
    >> Share

  122. SULTAN I, Cardounel A, Abdelkarim I, Kilic A, et al
    Right ventricle to pulmonary artery coupling in patients undergoing transcatheter aortic valve implantation.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313385. doi: 10.1136/heartjnl-2018-313385.
    >> Share

  123. HUTCHINGS DC, Anderson SG, Caldwell JL, Trafford AW, et al
    Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
    Heart. 2018;104:1244-1250.
    >> Share

  124. CHOUSOU PA, Pugh PJ
    How to deliver optimal cardiac resynchronisation therapy.
    Heart. 2018;104:1300-1307.
    >> Share

    July 2018
  125. PRASAD SB, Holland DJ, Atherton JJ
    Diastolic stress echocardiography: from basic principles to clinical applications.
    Heart. 2018 Jul 20. pii: heartjnl-2017-312323. doi: 10.1136/heartjnl-2017-312323
    >> Share

  126. LYON AR
    Heart failure resulting from cancer treatment: still serious but an opportunity for prevention.
    Heart. 2018 Jul 4. pii: heartjnl-2018-313493. doi: 10.1136/heartjnl-2018-313493.
    >> Share

  127. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.
    >> Share

  128. NANCHEN D
    Resting heart rate: what is normal?
    Heart. 2018;104:1048-1049.
    >> Share

  129. JARVIE JL, Metz TD, Davis MB, Ehrig JC, et al
    Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy.
    Heart. 2018;104:1187-1194.
    >> Share

    June 2018
  130. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.
    >> Share

  131. ZHU K, Knuiman M, Divitini M, Murray K, et al
    High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
    Heart. 2018;104:895-903.
    >> Share

  132. FRANCIS R, Lewis C
    Myocardial biopsy: techniques and indications.
    Heart. 2018;104:950-958.
    >> Share

    May 2018
  133. NG AT, Duan L, Win T, Spencer HT, et al
    Maternal and fetal outcomes in pregnant women with heart failure.
    Heart. 2018 May 25. pii: heartjnl-2018-313156. doi: 10.1136/heartjnl-2018-313156
    >> Share

  134. NADRUZ W JR, West E, Sengelov M, Grove GL, et al
    Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy.
    Heart. 2018 May 15. pii: heartjnl-2018-313234. doi: 10.1136/heartjnl-2018-313234
    >> Share

    April 2018
  135. APPS A, Lau J, Peterzan M, Neubauer S, et al
    Hyperpolarised magnetic resonance for in vivo real-time metabolic imaging.
    Heart. 2018 Apr 27. pii: heartjnl-2017-312356. doi: 10.1136/heartjnl-2017-312356
    >> Share

  136. LARSSON SC, Drca N, Bjorck M, Back M, et al
    Nut consumption and incidence of seven cardiovascular diseases.
    Heart. 2018 Apr 16. pii: heartjnl-2017-312819. doi: 10.1136/heartjnl-2017-312819
    >> Share

  137. ROHDE LE, Beck-da-Silva L
    Alcohol and the heart: the good, the bad and the worse in heart failure.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312924. doi: 10.1136/heartjnl-2017-312924.
    >> Share

  138. GUPTA D, Masoud A, Bartoletti S
    The Authors' reply.
    Heart. 2018;104:626.
    >> Share

  139. OTTO CM
    Heartbeat: phenotypic heterogeneity of bicuspid aortic valve disease.
    Heart. 2018;104:541-543.
    >> Share

    March 2018
  140. B SCHNABEL R, Pecen L, Engler D, Lucerna M, et al
    Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes.
    Heart. 2018 Mar 17. pii: heartjnl-2017-312569. doi: 10.1136/heartjnl-2017-312569
    >> Share

  141. BETTENCOURT P, Lourenco P
    Atrial fibrillation, a difficulty in the heart failure screening with natriuretic peptides.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312910. doi: 10.1136/heartjnl-2017-312910
    >> Share

  142. VAN DOORN S, Geersing GJ, Kievit RF, van Mourik Y, et al
    Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312781. doi: 10.1136/heartjnl-2017-312781
    >> Share

  143. NADRUZ W JR, Gioli-Pereira L, Bernardez-Pereira S, Marcondes-Braga FG, et al
    Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure.
    Heart. 2018 Mar 9. pii: heartjnl-2017-312869. doi: 10.1136/heartjnl-2017-312869.
    >> Share

  144. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.
    >> Share

  145. WAGNER F, Gebauer RA, Paech C
    Newborn in cardiogenic shock.
    Heart. 2018;104:467.
    >> Share

    February 2018
  146. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.
    >> Share

  147. WILSON AJ, Gill EK, Abudalo RA, Edgar KS, et al
    Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.
    Heart. 2018;104:293-299.
    >> Share

    January 2018
  148. WITTE KK, Patel PA, Walker AMN, Schechter CB, et al
    Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure.
    Heart. 2018 Jan 31. pii: heartjnl-2017-312539. doi: 10.1136/heartjnl-2017-312539
    >> Share

  149. SQUIRE I
    Socioeconomic status and outcomes in heart failure with reduced ejection fraction.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312814. doi: 10.1136/heartjnl-2017-312814
    >> Share

  150. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    >> Share

  151. WANG YC, Huang CW, Lin TW
    Acute heart failure with new-onset continuous murmur in a 26-year-old man.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312506. doi: 10.1136/heartjnl-2017-312506
    >> Share

  152. ZAKERI R, Cowie MR
    Heart failure with preserved ejection fraction: controversies, challenges and future directions.
    Heart. 2018 Jan 5. pii: heartjnl-2016-310790. doi: 10.1136/heartjnl-2016-310790.
    >> Share

    Age-related reduction of myocardial metabolic efficiency: Is it time to routinely measure myocardial metabolism to monitor cardiac health?
    Heart. 2018;104:88-89.
    >> Share

  154. NATHANIA M, Hollingsworth KG, Bates M, Eggett C, et al
    Impact of age on the association between cardiac high-energy phosphate metabolism and cardiac power in women.
    Heart. 2018;104:111-118.
    >> Share

    December 2017
  155. MCMURRAY JJV, Trueman D, Hancock E, Cowie MR, et al
    Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
    Heart. 2017 Dec 21. pii: heartjnl-2016-310661. doi: 10.1136/heartjnl-2016-310661
    >> Share

  156. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Heart. 2017;103:1977-1984.
    >> Share

  157. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    >> Share

  158. RAO P, Faddis M
    Cardiac resynchronisation therapy: current indications, management and basic troubleshooting.
    Heart. 2017;103:2000-2007.
    >> Share

    November 2017
  159. KIM TH, Kim H, Kim IC, Yoon HJ, et al
    Heart rate at first postdischarge visit and outcomes in patients with heart failure.
    Heart. 2017 Nov 25. pii: heartjnl-2017-312364. doi: 10.1136/heartjnl-2017-312364
    >> Share

  160. MORTON G, Masters J, Cowburn PJ
    Multidisciplinary team approach to heart failure management.
    Heart. 2017 Nov 23. pii: heartjnl-2016-310598. doi: 10.1136/heartjnl-2016-310598
    >> Share

  161. HUTCHINGS DC, Anderson SG, Trafford AW
    Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
    Heart. 2017;103:1745.
    >> Share

    October 2017
  162. LEE H, Lee SE, Park CS, Park JJ, et al
    Hyponatraemia and its prognosis in acute heart failure is related to right ventricular dysfunction.
    Heart. 2017 Oct 27. pii: heartjnl-2017-312084. doi: 10.1136/heartjnl-2017-312084
    >> Share

  163. CHOI KH, Lee GY, Choi JO, Jeon ES, et al
    Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Heart. 2017 Oct 5. pii: heartjnl-2017-311813. doi: 10.1136/heartjnl-2017-311813.
    >> Share

  164. BOTTLE A, Kim D, Aylin P, Cowie MR, et al
    Routes to diagnosis of heart failure: observational study using linked data in England.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312183. doi: 10.1136/heartjnl-2017-312183.
    >> Share

  165. PETRIE MC, Rocchiccioli P
    Coronary angiography in heart failure: when and why? Uncertainty reigns.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312200. doi: 10.1136/heartjnl-2017-312200.
    >> Share

  166. SINGH JSS, Burrell LM, Cherif M, Squire IB, et al
    Sacubitril/valsartan: beyond natriuretic peptides.
    Heart. 2017;103:1569-1577.
    >> Share

  167. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    >> Share

    August 2017
  168. SCHNELL F, Donal E
    Pharmacological strategies in heart failure with preserved ejection fraction: time for an individualised treatment strategy?
    Heart. 2017 Aug 18. pii: heartjnl-2017-312119. doi: 10.1136/heartjnl-2017-312119
    >> Share

  169. FERREIRA JP, Rossignol P, Demissei B, Sharma A, et al
    Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.
    Heart. 2017 Aug 10. pii: heartjnl-2017-311750. doi: 10.1136/heartjnl-2017-311750
    >> Share

  170. ZHENG SL, Chan FT, Nabeebaccus AA, Shah AM, et al
    Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311652. doi: 10.1136/heartjnl-2017-311652.
    >> Share

    July 2017
  171. TUEGEL C, Bansal N
    Heart failure in patients with kidney disease.
    Heart. 2017 Jul 17. pii: heartjnl-2016-310794. doi: 10.1136/heartjnl-2016-310794
    >> Share

  172. SCHMIDT M
    Interaction between body mass index and physical fitness in primary heart failure prevention.
    Heart. 2017 Jul 17. pii: heartjnl-2017-311504. doi: 10.1136/heartjnl-2017-311504
    >> Share

  173. MINAMINO-MUTA E, Kato T, Morimoto T, Taniguchi T, et al
    Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.
    Heart. 2017 Jul 6. pii: heartjnl-2016-311022. doi: 10.1136/heartjnl-2016-311022.
    >> Share

  174. D'AMARIO D, Amodeo A, Adorisio R, Tiziano FD, et al
    A current approach to heart failure in Duchenne muscular dystrophy.
    Heart. 2017 Jul 1. pii: heartjnl-2017-311269. doi: 10.1136/heartjnl-2017-311269.
    >> Share

  175. GROGAN M, Dispenzieri A, Gertz MA
    Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Heart. 2017;103:1065-1072.
    >> Share

    June 2017
  176. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684
    >> Share

  177. ROHDE LE, Biolo A
    The tip of the iceberg in the sub-Saharan Africa: unraveling the real world in the diagnosis and treatment of heart failure.
    Heart. 2017 Jun 5. pii: heartjnl-2017-311558. doi: 10.1136/heartjnl-2017-311558.
    >> Share

    May 2017
  178. CRUMP C, Sundquist J, Winkleby MA, Sundquist K, et al
    Aerobic fitness, muscular strength and obesity in relation to risk of heart failure.
    Heart. 2017 May 12. pii: heartjnl-2016-310716. doi: 10.1136/heartjnl-2016-310716
    >> Share

  179. CARLSON S, Duber HC, Achan J, Ikilezi G, et al
    Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa.
    Heart. 2017 May 10. pii: heartjnl-2016-310913. doi: 10.1136/heartjnl-2016-310913
    >> Share

  180. KUTYIFA V
    Gender-specific outcomes of cardiac resynchronisation therapy with or without defibrillator.
    Heart. 2017;103:732-733.
    >> Share

  181. OTTO CM
    Heartbeat: Cardiac resynchronization therapy with or without defibrillation: are women different?
    Heart. 2017;103:727-728.
    >> Share

    April 2017
  182. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    >> Share

    March 2017
  183. OTTO CM
    Heartbeat: Diabetes and heart failure.
    Heart. 2017;103:327-328.
    >> Share

  184. OTTO CM
    Heartbeat:Blood urea nitrogen to creatinine ratio predicts outcome in acute heart failure.
    Heart. 2017;103:399-401.
    >> Share

    February 2017
  185. ROSMINI S, Biagini E, O'Mahony C, Bulluck H, et al
    Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Heart. 2017;103:300-306.
    >> Share

    January 2017
  186. BARRA S, Providencia R, Duehmke R, Boveda S, et al
    Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.
    Heart. 2017 Jan 19. pii: heartjnl-2016-310677. doi: 10.1136/heartjnl-2016-310677
    >> Share

    December 2016
  187. SCHRANZ D, Akintuerk H, Voelkel NF
    'End-stage' heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation.
    Heart. 2016 Dec 23. pii: heartjnl-2015-309110. doi: 10.1136/heartjnl-2015-309110
    >> Share

  188. KINUGASA Y, Yamamoto K
    The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction.
    Heart. 2016 Dec 9. pii: heartjnl-2016-309995. doi: 10.1136/heartjnl-2016-309995.
    >> Share

  189. OTTO CM
    Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused?
    Heart. 2016;102:1855-1856.
    >> Share

    Heart transplantation in adult congenital heart disease.
    Heart. 2016;102:1871-1877.
    >> Share

    November 2016
  191. INGLIS SC, Clark RA, Dierckx R, Prieto-Merino D, et al
    Structured telephone support or non-invasive telemonitoring for patients with heart failure.
    Heart. 2016 Nov 18. pii: heartjnl-2015-309191. doi: 10.1136/heartjnl-2015-309191
    >> Share

    October 2016
  192. CHIMURA M, Onishi T, Tsukishiro Y, Sawada T, et al
    Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Heart. 2016 Oct 31. pii: heartjnl-2016-309746. doi: 10.1136/heartjnl-2016-309746
    >> Share

  193. TAJIK AA, Dickstein K
    What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Heart. 2016 Oct 14. pii: heartjnl-2015-308039. doi: 10.1136/heartjnl-2015-308039
    >> Share

  194. NUNEZ J
    Blood urea nitrogen to creatinine ratio in acute heart failure: an old concept brought to reality?
    Heart. 2016 Oct 14. pii: heartjnl-2016-310536. doi: 10.1136/heartjnl-2016-310536
    >> Share

  195. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
    Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
    >> Share

  196. BANSAL N, Szpiro A, Masoudi F, Greenlee RT, et al
    Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Heart. 2016 Oct 14. pii: heartjnl-2016-309842. doi: 10.1136/heartjnl-2016-309842
    >> Share

    September 2016
  197. RAHIMI K
    The long and unfinished journey of hyperglycaemia and heart failure research.
    Heart. 2016 Sep 29. pii: heartjnl-2016-310336. doi: 10.1136/heartjnl-2016-310336
    >> Share

  198. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    >> Share

  199. MATSUE Y, van der Meer P, Damman K, Metra M, et al
    Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure.
    Heart. 2016 Sep 22. pii: heartjnl-2016-310112. doi: 10.1136/heartjnl-2016-310112
    >> Share

  200. NASR E, Ibrahim M, Yacoub M
    Heart failure in a neonate with multiple cardiac masses.
    Heart. 2016 Sep 21. pii: heartjnl-2016-310251. doi: 10.1136/heartjnl-2016-310251
    >> Share

  201. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    >> Share

  202. SKRTIC S, Cabrera C, Olsson M, Schnecke V, et al
    Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309806. doi: 10.1136/heartjnl-2016-309806
    >> Share

  203. KIM CH, Al-Kindi SG, Jandali B, Askari AD, et al
    Incidence and risk of heart failure in systemic lupus erythematosus.
    Heart. 2016 Sep 9. pii: heartjnl-2016-309561. doi: 10.1136/heartjnl-2016-309561.
    >> Share

    June 2016
  204. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    >> Share

    February 2016
  205. LAM CS, Lund LH
    Microvascular endothelial dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:257-9.
    >> Share

  206. OTTO CM
    Heartbeat: Microvascular dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:255-6.
    >> Share

    December 2015
  207. HODES AR, Tichnell C, Te Riele AS, Murray B, et al
    Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308624. doi: 10.1136/heartjnl-2015-308624
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016